Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
Sunitinib and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Chemotherapy
| Conditions: | Cancer |
| Start Date: | November 1, 2008 |
| Phase: | Phase I |
| Status: | Completed |
| NCT ID: | NCT00813423 |
| Study Type: | Interventional |
| Intervention: | Drug: hydroxychloroquine|Drug: sunitinib malate |
| Study Design: | Masking: Open Label|Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | University of Medicine and Dentistry New Jersey|National Cancer Institute (NCI) |
| Ages: | Adult|Senior |
| Enrollment: | 20 |
| Funded By: | Other|NIH |
| First Received: | December 20, 2008 |
| End Date: | |
| Last Updated: | December 10, 2009 |
| Last Verified: | December 1, 2009 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
